Skip to content

The Moment Study: Mixed Method E-cigarette Study

A Mixed Method EMA Assessment of Cognition and Behavior Among New ENDS Users: An Observational Cohort Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02261363
Acronym
Moment
Enrollment
117
Registered
2014-10-10
Start date
2014-08-31
Completion date
2016-08-31
Last updated
2025-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking

Brief summary

The universe of tobacco products is expanding, with new noncombustible products gaining popularity even as the reduction in prevalence of cigarette smoking slows or stalls. E-cigarettes, or Electronic Nicotine Delivery Systems (ENDS), are the most prevalent of these emerging noncombustible products. With sales increasing rapidly and more efficient pulmonary delivery devices under development, ENDS are likely to play an increasing role in the future tobacco market. Little is known about the cognitions and behaviors leading to or sustaining ENDS use. Smokers may use ENDS to subvert smoking restrictions, to reduce perceived smoking harms, or for smoking cessation. Evidence about ENDS use is emerging from national surveillance and laboratory research, but the majority of information on ENDS is limited to retrospective surveys and convenience samples of White male ENDS users. The investigators research suggests Black smokers are less likely than White smokers to try and be current ENDS users, perhaps due to a greater degree of perceived harm associated with ENDS, a preference for menthol, or cultural norms. Thus, it is timely and critical to study how all smokers, including Blacks and menthol smokers, experience and initiate ENDS use employing valid, innovative research methods.

Interventions

OTHEREcig group 1

E-cigarettes were 3% nicotine and of tobacco or menthol flavor, depending on participants' usual flavor preference.

Sponsors

Truth Initiative
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Participants must: 1. be aged 18 years or older 2. reside in Washington, D.C. metro area (including VA and MD suburbs) 3. be proficient in English 4. be daily smoker with at least 5 years of established daily smoking * A person will be categorized as a daily smoker if he reports daily smoking of at least 8 cigarettes a day for the past 5 years, and records an exhaled air carbon monoxide (CO) level \> 8 parts-per-million (ppm) at the baseline in-person meeting. * Daily smokers will be eligible for the main study if they do not intend to quit in the next 30 days. * If they do intend to quit in the next 30 days, eligible daily smokers will be enrolled in the second arm of the study. 5. not taking smoking cessation medications; 6. smoked LCC/cigars/hookah less than 5 times in last 30 days 7. have not used other tobacco products in last 30 days 8. have not used an ENDS product (electronic cigarette) in the last 30 days 9. be interested in trying an ENDS 10. have an iPhone or Android that allows installation of applications and use it daily 11. have a phone plan that allows unlimited text messages 12. be willing to travel to the data collection cite four times in three weeks 13. not be breastfeeding or planning to become pregnant 14. not have heart disease/uncontrolled blood pressure 15. not have psychosis/suicidal thoughts 16. not be currently enrolled in an alcohol treatment program 17. not be out of town for more than 5 nights in the next 6 weeks

Exclusion criteria

* Individuals who do not satisfy the criteria above will not be eligible for this study. * There will be no involvement of vulnerable populations.

Design outcomes

Primary

MeasureTime frameDescription
Cigarette UseStudy Day 7, Week 2Change in the average number of cigarettes per day comparing average cigarettes per day on study day 6 (last day of cigarette-only use) to average cigarettes per day on study day 7 (first day of e-cigarette and cigarette use).

Countries

United States

Participant flow

Participants by arm

ArmCount
Ecig Group
This is an interventional study with one group.
96
Total96

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up21

Baseline characteristics

CharacteristicEcig Group
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
96 Participants
Age of first cigarette
<=14 years
31 participants
Age of first cigarette
15-18 years
48 participants
Age of first cigarette
19-24 years
12 participants
Age of first cigarette
25-55 years
5 participants
Educational attainment
high school graduate or lower
30 participants
Educational attainment
some college or more
66 participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
92 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Fagerstrom test
<=5
16 participants
Fagerstrom test
6-7
57 participants
Fagerstrom test
8-10
23 participants
Menthol preference
Menthol
72 participants
Menthol preference
non-menthol
24 participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
65 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
31 Participants
Sex: Female, Male
Female
51 Participants
Sex: Female, Male
Male
45 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 96
serious
Total, serious adverse events
0 / 96

Outcome results

Primary

Cigarette Use

Change in the average number of cigarettes per day comparing average cigarettes per day on study day 6 (last day of cigarette-only use) to average cigarettes per day on study day 7 (first day of e-cigarette and cigarette use).

Time frame: Study Day 7, Week 2

ArmMeasureValue (MEAN)
Ecig Group 1Cigarette Use-1.82 cigarettes

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026